Jim Ruble portrait
  • Assistant Dean for Student Affairs, College Of Pharmacy
  • Associate Professor (Clinical), Pharmacotherapy
  • Faculty Relations Specialist, Office Of Sr Vp Health Sci
  • Adjunct Associate Professor, Internal Medicine
  • Adjunct Associate Professor, College Of Law
  • Adjunct Associate Professor, Pharmaceutical Chemistry

Research Keywords

  • Legal issues in health administration, health care delivery, and higher education
  • Ethics
  • Conflict and Mediation

Presentations

  • Negotiation Essentials. Leadership Development Seminar, University of Utah, Salt Lake City, Utah. Presentation, Presented, 03/2020.
  • Communication, Leadership, and Conflict Competence. Senior Leadership Development Conference, University of Utah Health, Salt Lake City, Utah. Presentation, Presented, 02/2020.
  • Ethics in Pharmacy and Law: Practice implications of anti-discrimination standards in MRPC 8.4(g) and ACA section 1557. American Society for Pharmacy Law – Fall Seminar. Hilton Head, South Carolina. Presentation, Presented, 11/2018.
  • Ethical Dilemmas in Pharmacotherapy – Communication and Conflict Resolution Skills for the Pharmacy Learner Continuum. Special Presentation, American Association of Colleges of Pharmacy (AACP), AACP Annual Meeting, Nashville, Tennessee. Presentation, Presented, 07/2017.
  • Reducing Risk and Maintaining Empathy: Professional Practice Tips for Risk Management & Strengthening Relationships. Anticoagulation Forum Boot Camp. Los Angeles, California. Presentation, Presented, 04/2017.
  • Medical Aid-in-Dying, Pharmacy, Public Policy, and Perspectives. Greater New York Hospital Association, Metropolitan New York City. Presentation, Presented, 04/2017.
  • Death-With-Dignity: Legal, Ethical, Clinical and Pharmaceutical Perspectives. 18th Annual Conference on Emerging Issues in Healthcare Law, American Bar Association, New Orleans, Louisiana. Presentation, Presented, 03/2017.
  • Educator’s Session – Formative and Summative Assessment in Pharmacy Law Education. American Society for Pharmacy Law – Fall Seminar. Austin, Texas. Presentation, Presented, 11/2016.
  • Hemophilia Managed Care Review Board – Health Economics and Pharmacoeconomics Assessment – Analyzing Available Data to Assess the Value of Treatment Options and Collaborative Care Management. Web-based Continuing Education Program. Philadelphia, Pennsylvania. Panel, Presented, 06/2016.
  • Death With Dignity, Pharmacy and HB 391. Utah Society of Health-System Pharmacists, McKay-Dee Hospital, Ogden, Utah. Presentation, Presented, 09/2015.
  • Lethal Injection in the United States Criminal Justice System: A Modern Kairos? Hinckley Institute at The University of Utah, Salt Lake City, Utah. Presentation, Presented, 02/2015.
  • Pharmacy and the Continuum of Lethal Injection. American Society for Pharmacy Law – Fall Seminar. Indian Wells, California. Presentation, Presented, 11/2014.
  • Educator’s Session – Teaching Federal Pharmacy Law. American Society for Pharmacy Law – Fall Seminar. Indian Wells, California. Presentation, Presented, 11/2014.
  • Prescription Drugs and Poisonings: Exploring the Landscape – Legal Perspective. Utah Poison Control Center 60th Anniversary Symposium. Salt Lake City, Utah. Presentation, Presented, 10/2014.
  • Pharmacist Providers: Professional Evolution or Passing Fancy? Utah Therapeutics and Pharmacy Law Continuing Education Program. Roseman University of Health Sciences. Salt Lake City and Logan, Utah. Presentation, Presented, 02/2014.
  • Compounding Paradigm Shift: A New Regulatory Landscape. American Society for Pharmacy Law – Fall Seminar. Jacksonville, Florida. Presentation, Presented, 11/2013.
  • Communication of Risk in Pharmacotherapy: More than just a four-letter word. Department of Pharmacotherapy, College of Pharmacy. Presentation, Presented, 11/11/2011.
  • Pharmacy Law Review and Refresher Course. University of Utah College of Pharmacy Continuing Pharmacy Education Program, Health Sciences Education Building, University of Utah, Salt Lake City, Utah. (Full-day CPE program in Pharmacy Law and Ethics). Presentation, Presented, 05/17/2011.
  • Ethics of High Cost Oncology Drugs: Identifying Victims, Villains, and Values. University of Utah Health Care, Department of Pharmacy Services, Oncology Pharmacy Residency Program. Presentation, Presented, 03/07/2011.
  • Ethics Panel Discussion: A continuum of pharmacy issues at end-of-life. Utah Society of Health-System Pharmacy Mid-Winter Meeting. Health Sciences Education Building. Panel, Presented, 02/26/2011.
  • Pharmacist Liability: A case study. University of Utah Health Care, Department of Pharmacy Services. Salt Lake City, Utah. Presentation, Presented, 01/10/2011.
  • Pharmacist Liability: A case study. Department of Pharmacy Services, Intermountain Medical Center. Murray, Utah. Presentation, Presented, 11/01/2010.
  • Criminal Liability for Compounding Errors: A discussion of recent cases. Utah Society of Health System Pharmacy, Annual Meeting, Salt Lake City, Utah. Presentation, Presented, 09/10/2010.
  • Risk Management and the Lexicon of Pharmacy Practice. Task Force on Future Curricular Revision, University of Utah College of Pharmacy. Salt Lake City, Utah. Presentation, Presented, 09/01/2010.
  • Pharmacy Law Review and Refresher Course. University of Utah College of Pharmacy Continuing Pharmacy Education Program, Health Sciences Education Building, University of Utah, Salt Lake City, Utah. (Full-day program in Pharmacy Law and Ethics). Presentation, Presented, 05/01/2010.
  • USP <797> -- Planning, implementation and enforcement: successes and struggles. Southern Nevada Society of Health-System Pharmacists, Mid-year Meeting. Henderson, Nevada. Presentation, Presented, 03/26/2010.
  • Pharmacist Liability: A case study. Utah Society of Health-System Pharmacists Annual Meeting. Davis Convention Center, Layton, Utah. Presentation, Presented, 02/01/2010.
  • Brands, Generics, and Pay-for-Delay: Implications in Patient Care. University of Southern Nevada, Winter CPE Meeting. South Jordan, Utah, and Logan, Utah. Presentation, Presented, 01/31/2010.
  • Disclosing a Dispensing Error: Ethical Reasoning. Utah Pharmacists Association, Fall Meeting. Wyndam Hotel and Convention Center, Salt Lake City, Utah. Presentation, Presented, 11/15/2009.
  • Is Compounding illegal or unethical? A discussion of law and ethics in pharmaceutical compounding. University of Utah College of Pharmacy Seminar. Presentation, Presented, 07/01/2009.
  • Pharmacy Law Review and Refresher Course. University of Utah College of Pharmacy Continuing Pharmacy Education Program, Health Sciences Education Building, University of Utah, Salt Lake City, Utah. (Full-day program in Pharmacy Law and Ethics). Presentation, Presented, 05/01/2009.
  • Complying with Controlled Substances Laws While Maintaining Compassion for Patients. Continuing Education Program, University of Southern Nevada, South Jordan, Utah. Presentation, Presented, 05/01/2009.
  • Equipoise and Clinical Research in an Academic Medicine Environment. University of Utah Health Care, Ethics Committee, Educational Presentation, Salt Lake City, Utah. Presentation, Presented, 04/11/2009.
  • Conflict-of-Interest. Fall Continuing Education Program, University of Utah College of Pharmacy, Salt Lake City, Utah. Presentation, Presented, 10/01/2008.
  • Pharmacy Law Review and Refresher Course. University of Utah College of Pharmacy Continuing Pharmacy Education Program, Health Sciences Education Building, University of Utah, Salt Lake City, Utah. (Full-day program in Pharmacy Law and Ethics). Presentation, Presented, 05/01/2008.
  • Applied Bioethics and Withdrawal of Life-support in Dying Patients. 14th Annual Winter CE Program, University of Arizona College of Pharmacy, Park City, Utah. Presentation, Presented, 12/27/2007.
  • Review of Medicare/Medicaid Fraud and Abuse. 13th Annual Winter CE Program, University of Arizona College of Pharmacy, Park City, Utah. Presentation, Presented, 12/27/2007.
  • Investigational New Drug Applications: Information for Principal Investigators and IRB Panel Members. Institutional Review Board Annual Retreat, University of Utah, Salt Lake City, Utah. Presentation, Presented, 08/01/2007.
  • Pharmacy Law Review and Refresher Course. University of Utah College of Pharmacy Continuing Pharmacy Education Program, Health Sciences Education Building, University of Utah, Salt Lake City, Utah. (Full-day program in Pharmacy Law and Ethics). Presentation, Presented, 05/01/2007.
  • Dealing with Conflict of Interest Ethical Issues. 13th Annual Winter CE Program, University of Arizona College of Pharmacy, Park City, Utah. Presentation, Presented, 12/28/2006.
  • INDA’s – Investigational New Drug Applications: An introduction in 10 questions. Institutional Review Board Annual Retreat, University of Utah, Salt Lake City, Utah. Presentation, Presented, 08/01/2006.
  • Applied Bioethics and Withdrawal of Life-Support in Dying Patients. Grand Rounds, Department of Pharmacy Services, University Health Care, University of Utah, Salt Lake City, Utah. Presentation, Presented, 05/01/2006.
  • Pharmacist Refusal to Dispense: An overview of legal and ethical issues. Utah Pharmacists Association Annual Meeting, Dixie Center, Saint George, Utah. Presentation, Presented, 04/26/2006.
  • Pharmacist Refusal to Dispense: An overview of legal and ethical issues. 12th Annual Winter CE Program, University of Arizona College of Pharmacy, Park City, Utah. Presentation, Presented, 12/27/2005.
  • Business Law Primer for Pharmacists. 11th Annual Winter CE Program, University of Arizona College of Pharmacy, Park City, Utah. Presentation, Presented, 12/28/2004.
  • Negligence Update: Pharmacists Duty to Warn. 11th Annual Winter CE Program, University of Arizona College of Pharmacy, Park City, Utah. Presentation, Presented, 12/28/2004.
  • Federal Legislation and Pharmacy Practice Update. 10th Annual Winter CE Program, University of Arizona College of Pharmacy, Park City, Utah. Presentation, Presented, 12/28/2003.
  • Primer on Federal and State Administrative Law: FDA, FTC, DEA and State Pharmacy Boards. 10th Annual Winter CE Program, University of Arizona College of Pharmacy, Park City, Utah. Presentation, Presented, 12/28/2003.
  • Fundamentals of Intellectual Property for the Neurologist and Neuroscientist. Grand Rounds, Department of Neurology, University of Utah School of Medicine, Salt Lake City, Utah. Presentation, Submitted, 11/01/2003.
  • Navigating Federal Drug Law: 1987-2003: Significant Legislation, Rx-to-OTC switch, Drug Importation. Annual Meeting, Utah Society of Health-System Pharmacists, University of Utah College of Pharmacy, Salt Lake City, Utah. Presentation, Presented, 10/01/2003.
  • Ruble J, Constantino T, Godsey C, et al. (12/08/1998). Topiramate (TPM) use in refractory epilepsy patients ineligible for surgical treatment [Abstract #100231]. Poster session presented at American Epilepsy Society 52nd Annual Meeting, Sheraton Convention Center, San Diego, CA. Poster, Presented, 1999.
  • Forshew DA, Ruble J, Bromberg MB. (11/16/1998). A survey of ALS/MND specialists for medication preferences for relief of symptoms associated with ALS/MND. Platform Presentation. Poster session presented at The 9th International Symposium on ALS/MND, Park Hilton, Munich, Germany. Poster, Presented, 1998.

Languages

  • English, fluent.
  • Spanish, basic.

Publications

  • Pan RJ, Ruble JH. A Commentary on Ethical Decision-Making in the Pharmacy Profession and the APhA Code of Ethics. Journal of the American Pharmacists Association. Accepted for publication; available on line beginning 20 November 2020. doi.org/10.1016/j.japh.2020.10.021. Accepted, 11/2020.
  • Rosenberg E, Albert EL, Mospan GA, Panther S, Ruble J, Stein RL. A Pilot Study Regarding Pharmacy Law Education Across Doctor of Pharmacy Programs. Am J Pharm Educ. 2020;84(2):7172. doi: 10.5688/ajpe7172. Published, 02/2020.
  • Tak CR, Gunning K, Kim J, Sherwin CM, Ruble JH, Nickman NA, Biskupiak JE. The effect of a prescription order requirement for pharmacist-administered vaccination on herpes zoster vaccination rates. Vaccine. 2019 Jan 21;37(4):631-636. doi: 10.1016/j.vaccine.2018.12.003. Epub 2018 Dec 15. Published, 01/2019.
  • Ruble JH. Compounded medications in pain management: customized rational polypharmacy. In: Aronoff GM, editor. Medication management of chronic pain: what you need to know. Bloomington, IN:Trafford Publishing; 2017. Published, 12/2016.
  • Feehan M, Durante R, Ruble JH, Munger MA. Qualitative Interviews about Pharmacist Prescribing in the Community Setting. Am J Health-Syst Pharm. 2016 Sep 15;73(18):1456-61. doi: 10.2146/ajhp150691. Published, 09/2016.
  • Ruble JH. Evaluation of US Federal Legislation for Opioid Abuse: 1973-2016. J Pain Palliat Care Pharmacother. 2016 Sep;30(3):218-24. doi: 10.1080/15360288.2016.1211213. Published, 09/2016.
  • Ruble JH, Brixner DA. Comment & Response: Outpatient Pharmacy Expenditures for Children with Serious Chronic Illness in California, 2010-2012. JAMA. 2016;315(7):706. doi:10.1001/jama.2015.16978. Published, 02/2016.
  • Ruble JH. Tools for "decloaking" the elephant in the room: Conflict-of-interest, Shared Decision-Making and Patient-Centered Care [Commentary]. J Pain Palliat Care Pharmacother. 2015 June;29(2). Accepted for Publication. Accepted, 04/2015.
  • Munger MA, Ruble JH, Nelson SD, Ranker L, Petty RC, Silverstein S, et al. Naitonal Evaluation of Prescriber Drug Dispensing. Pharmacotherapy. 2014;34(10):1012-21. Published, 10/2014.
  • Ruble JH. The "death" of lethal injection as we know it? An opportunity to reflect on the role of chemical execution in the US criminal justice system [Commentary]. J Pain Palliat Care Pharmacother. 2014;28(3):276-81. Published, 09/2014.
  • Ruble JH. Prescriber-Pharmacist Collaboration: Re-engineering the Partnership to Optimize Pain Patient Care [Commentary]. J Pain Palliat Care Pharmacother. 2013;27(4):365-6. Published, 12/2013.
  • Shrewsbury R, Augistin S, Birnie C, Nagel K, Ray D, Ruble J, Scolaro K, Athay Adams J. AACP REport: Assessment and REcommendations of Compounding Education in AACP Member Institutions. Am J Pharm Educ. 2012;76(7):S9. Published, 09/2012.
  • Ruble JH. Distribution of Controlled Substances in the US Supply Chain: Where does the Compass Point? [Commentary] J Pain Palliat Care Pharmacother. 2012;26:251-3. Published, 09/2012.
  • Ruble J. Off-label prescribing of medications for pain: Maintaining optimal care at an intersection of law, public policy and ethics. J Pain Palliat Care Pharmacother. 2012;26:146-52. Published, 06/2012.
  • Ruble JH. Baxter v. Montana, Libertarianism, and End-of-Life: The Ripe Time for a Paradigm Shift. J Pain Palliat Care Pharmacother 2010;24(3):263-70. Published, 09/03/2010.
  • Ruble J. (2008). USP Chapter <797> Compliance: Important legal issues. [available at: http://www.pppmag.com/pp-p-june-issue-2008/cover-story-pharmacy-s-legal-liability-and-usp.html]. Pharmacy Purchasing & Products (Issue Cover Article, 5, pp. 16, 18, 20). Published, 09/2008.
  • Ruble J. (2008). Impact safety, efficiency, and the bottom line with premixed IV products. [available at: http://www.pppmag.com/pp-p-february-issue-2008/premixed-iv-products.html]. Pharmacy Purchasing & Products (5, pp. 34, 36, 38). Published, 03/2008.
  • Ruble J, Hill GK. (2005 Sept-Oct). Inadvertent Public Disclosure and Possible Loss of Intellectual Property Rights. [article available on-line at: http://www.nutraceuticalmag.com/nbtmag/features-inside.jsp?filename=Articles/Features/1128610014732_October_2005_regulatory_affairs1.htm]. Nutraceutical Business & Technology (1, pp. 34-40). Published, 07/2005.
  • Ruble J, Koberstein W, ed. (2005 June). Special Report: The Secure IPO Launch Plan – A Virtual Roundtable. [Roundtable participant/contributor; trade journal publication] [article available on-line at: http://www.bioexecutiveintl.com/default.asp?page=articles ]. BioExecutive International (1, pp. 58-67). Published, 05/2005.
  • Ruble J, Matsuo F. (1999 Sept). Antiepileptic-induced cutaneous drug reactions: Incidence, mechanisms, and management. [International, peer-reviewed, medical journal publication]. CNS Drugs, 12(3), 215-36. Published, 09/1999.
  • Ruble J, Muncey LA. (1997). Beta-adrenergic agonists in the treatment of asthma. [peer-reviewed, pharmaceutical journal publication]. J Pharm Care Pain Symptom Control, 5(4), 49-56. Published, 12/1997.
  • Goeser S, Ruble J. (1997). Melatonin: Historical and clinical perspectives. [peer-reviewed, pharmaceutical journal publication]. J Pharm Care Pain Symptom Control, 5(1), 37-49. Published, 03/1997.
  • Subach RA, Ruble J. (1996 Jul 15). Misprint of dosage interval for liposomal doxorubicin hydrochloride [Letter to the editor]. Am J Health Syst Pharm, 53(14), 1727. Published, 08/1996.